Christian Angermayer
Founder & CEO @ Apeiron Investment Group
London, United Kingdom
Christian Angermayer is a seed investor at Apeiron Investment Group in London focused on Financial Services and FinTech. Christian Angermayer is based out of London, England and is the Co-Founder & Executive Chairman of Enhanced Games. Christian Angermayer attended the University of Bayreuth.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 34%
Last updated:
For AI agents: llms.txt
Industries Christian Angermayer invests in
Stages Christian Angermayer invests in
Countries Christian Angermayer invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $588k–$5M
- Series A
- $8M–$45M
- Series B
- $4.5M–$125M
Investment Focus
Industry
- Financial Services 7 (15%)
- FinTech 6 (13%)
- Blockchain 6 (13%)
- Life Science 5 (11%)
- Biotechnology 5 (11%)
Stage
- Seed 12 (26%)
- Series A 9 (19%)
- Series B 6 (13%)
- Venture - Series Unknown 5 (11%)
- Angel 4 (9%)
Country
- Germany 13 (28%)
- United States 6 (13%)
- United Kingdom 6 (13%)
- Cayman Islands 2 (4%)
- Canada 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Invyted is a marketing tool that connects influencers with venues. | Seed / Oct 14, 2025 | ||
| Plasma is an operational setting that supports payments, real-world assets, and DeFi, with trustless settlement on Bitcoin. | $3.5M / Seed / Oct 18, 2024 | ||
| Enhanced Games is the contemporary reinvention of the Olympic Games without drug testing. | Seed / Jan 30, 2024 | ||
| Nextmarkets is dedicated to `helps private investors to operate in a sustainable and better educated manner on the stock exchange.For this purpose, the company developed a very easy-to-use trading platform in which private investors can trade more than 1,000 CFDs on equities , foreign exchange ( forex , FX ), bonds and commodities veryintuitively - via web and mobile apps . It is scientifically proven that more than 80 percent of all private investors fail on the stock market . This has predominantly behavioral economic reasons. | $11M / Venture - Series Unknown / Apr 18, 2023 | ||
| Razor is a global consumer holding company that partners with e-commerce merchants to acquire and scale brands. Razor uses significant growth capital with extensive e-commerce expertise in order to take these acquired merchants to the next stage of development. Razor focuses on specific product categories, long-term value enhancement, andfirst-class customer satisfaction. | $70M / Series C / Dec 20, 2022 | ||
| Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. | $35M / Series B / Oct 25, 2022 | ||
| TRIP is a CBD brand that sells wellness products infused with adaptogens. Its product offered are Vegan, gluten-free, and no added sugar. | $12M / Series A / Aug 22, 2022 | ||
| Finclusion is a FinTech accelerating company that provides financial services and credit products using AI-powered and data-driven lending for fraud prevention and credit granting. The company also offers buy-now-pay-later (BNPL) services, salary advance schemes, loan services, and transactional banking to individuals and SMEs across 5countries—South Africa, Eswatini, Namibia, Kenya, and Tanzania. | $20M / Angel / Jan 18, 2022 | ||
| Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases. | $21M / Series A / Dec 13, 2021 | ||
| thirdweb is a developer tool accelerating teams building web3 apps, NFTs, marketplaces, DAOs and more. We provide powerful SDKs for developers. Deploy custom or pre-built smart contracts. | $5M / Seed / Dec 13, 2021 | ||
| See all 47 investments → | |||
Co-Investors
About Apeiron Investment Group
Apeiron Investment Group focuses in Germany on Financial Services (especially fintech), Internet and Technology (from ecommerce to deep tech), Life Sciences, Media, Real Estate and Natural Resources. Apeiron completes deals across the entire lifecycle and balance sheet of a company, from non-listed Seed/Start Up investments to larger scaleRestructuring and Special Situations deals (mostly listed).
Apeiron Investment Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jefim Gewiet
Managing Director
|
|||
|
Christian Angermayer
Founder & CEO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Christian Angermayer invest in?
Christian Angermayer invests primarily in Financial Services, FinTech and Blockchain startups, most often at Seed and Series A stage. Most of the 47 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Christian Angermayer invest in?
Christian Angermayer typically joins rounds of $588k–$5M at Seed, $8M–$45M at Series A and $4.5M–$125M at Series B. These are whole funding-round sizes, not Christian Angermayer's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Christian Angermayer took part in.
How do I contact Christian Angermayer?
Public channels for Christian Angermayer include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christian Angermayer last invest?
The most recent investment recorded for Christian Angermayer closed in Oct 2025. Shizune tracks 47 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
